News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,036 signal articles · 527 in last 24h · 103,484 total before filter · latest 32m ago

527last 24h

2509last 7d

482● bullish (7d)

257● bearish (7d)

197publishers

All Macro242 Earnings1479 M&A140 Regulatory16 Product4 Analyst29

✕ clear all filtersticker: GILDSentiment:bullish neutral bearish show all (incl. clickbait)

Insider Monkey38d agobullish

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]

GILD MRK ^GSPC

Stocktwits74d agobullish

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment

U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus.

GILD